Background : We aimed to evaluate the long-term pancreatic functional outcomes including pancreas-volumetry of pancreaticoduodenectomy for peri-ampullary neoplasms.

Methods : This retrospective study enrolled 353 consecutive patients with at least 12-month follow-up who underwent elective pancreaticoduodenectomy for peri-ampullary neoplasms in a single university hospital between January 2011 and December 2020. Perioperative and postoperative outcomes, long-term endocrine function of pancreas, and pancreatic volume changes at 12 months postoperatively were evaluated.

Results : Mean age was 65.4 and sex ratio was 1.38. The proportion of pre-diagnosed diabetes mellitus was 31.4%. The origin of the peri-ampullary neoplasm was in the order of pancreas (49.0%), common bile duct (27.2%), ampulla of Vater (18.4%), and duodenum (5.4%). Clinically relevant postoperative pancreatic fistula rate was 22.4%. The postoperative 1-, 3-, 6-, and 12-month proportion of diabetes mellitus diagnosed before surgery plus new-onset diabetes mellitus after surgery were 39.7%, 42.8%, 43.9%, and 49.6%, respectively. The preoperative, postoperative 1-, 3-, 6-, and 12-month mean volume of pancreas were 82.3ml, 38.7ml, 28.1ml, 24.9ml, and 25.5ml, respectively. In multivariate analysis, significant differences were observed in operation time (HR 1.008, p=0.012), remnant pancreatic volume 12 months after surgery (HR 0.773, p=0.021), and changes in remnant pancreatic volume 12 months after surgery (HR 1.120, p=0.028) between the ‘No DM after PD’ and ‘New onset DM after PD’ groups.

Conclusions : Pancreatic endocrine function and pancreatic volume continue to decline for at least 12 months after pancreaticoduodenectomy for peri-ampullary neoplasm. Further studies on the cause of pancreatic endocrine dysfunction and decreased remnant pancreatic volume after pancreaticoduodenectomy are needed.